Genomic characterization of an extensively drug-resistant KPC-2-producing Klebsiella pneumoniae ST855 (CC258) only susceptible to ceftazidime-avibactam isolated in Brazil.

[1]  B. F. Araújo,et al.  IncX3 plasmid harboring a non-Tn4401 genetic element (NTEKPC) in a hospital-associated clone of KPC-2-producing Klebsiella pneumoniae ST340/CG258. , 2017, Diagnostic microbiology and infectious disease.

[2]  B. Kreiswirth,et al.  Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections , 2016, Antimicrobial Agents and Chemotherapy.

[3]  B. Moreira,et al.  Modified Carba NP test for the detection of carbapenemase production in gram-negative rods: optimized handling of multiple samples , 2016, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[4]  S. Pournaras,et al.  Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. , 2016, International journal of antimicrobial agents.

[5]  F. Chang,et al.  Quantification and comparison of virulence and characteristics of different variants of carbapenemase-producing Klebsiella pneumoniae clinical isolates from Taiwan and the United States. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  N. Aksöz,et al.  Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. , 2015, Acta biochimica Polonica.

[7]  C. Giske,et al.  Global dissemination of extensively drug‐resistant carbapenemase‐producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control , 2015, Journal of internal medicine.

[8]  G. Rossolini,et al.  Update on the antibiotic resistance crisis. , 2014, Current opinion in pharmacology.

[9]  L. N. Andrade,et al.  Expansion and Evolution of a Virulent, Extensively Drug-Resistant (Polymyxin B-Resistant), QnrS1-, CTX-M-2-, and KPC-2-Producing Klebsiella pneumoniae ST11 International High-Risk Clone , 2014, Journal of Clinical Microbiology.

[10]  H. Giamarellou,et al.  Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches , 2014, Expert opinion on pharmacotherapy.

[11]  Ana Tereza Ribeiro de Vasconcelos,et al.  Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms , 2014, BMC Genomics.

[12]  Aaron E. Darling,et al.  A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data , 2014, Bioinform..

[13]  G. Visani,et al.  Resistant chronic myeloid leukemia beyond tyrosine-kinase inhibitor therapy: which role for omacetaxine? , 2014, Expert opinion on pharmacotherapy.

[14]  C. Giske,et al.  High Proportion of Intestinal Colonization with Successful Epidemic Clones of ESBL-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Ecuador , 2013, PloS one.

[15]  T. Akiyama,et al.  The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolates. , 2013, International journal of antimicrobial agents.

[16]  J. Karlowsky,et al.  Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination , 2013, Drugs.

[17]  V. Zahner,et al.  Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). , 2013, The Journal of antimicrobial chemotherapy.

[18]  P. Higgins,et al.  Characterization of RarA, a Novel AraC Family Multidrug Resistance Regulator in Klebsiella pneumoniae , 2012, Antimicrobial Agents and Chemotherapy.

[19]  R. Widen,et al.  Rapid detection of carbapenemase genes by multiplex real-time PCR. , 2012, The Journal of antimicrobial chemotherapy.

[20]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  M. Falagas,et al.  Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[22]  B. Swaminathan,et al.  Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. , 2006, Foodborne pathogens and disease.

[23]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[24]  G. P. Harding,et al.  A general method for detecting and sizing large plasmids. , 1995, Analytical biochemistry.